Ionis Pharmaceuticals Inc (IONS) income statement
IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/303% below fair value
$27.39+0.43 (+1.59%)
Close on Nov 18, 2026Market cap $4.55BP/E –Yield –
Ionis Pharmaceuticals Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 98.2%
- Operating margin
- -68.0%
- Net margin
- -64.7%
- Return on equity, FY2025
- -70.8%
Financial strength
- Current ratio
- 7.89
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 110.9%
Valuation
- P/E ratio
- –
- Price to sales
- 5.21
- Price to book
- 10.35
- Dividend yield
- –
See a number that looks wrong?